Cargando…

Ethambutol and pyrazinamide-induced toxic epidermal necrolysis in an immunocompetent adult with tuberculosis

Detalles Bibliográficos
Autores principales:	Das, Sibes Kumar, Jana, Pulak Kumar, Bandyopadhyay, Arun Kumar, Biswas, Indranil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letters to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276047/ https://www.ncbi.nlm.nih.gov/pubmed/22345926 http://dx.doi.org/10.4103/0970-2113.92376

Ejemplares similares

Ofloxacin-induced toxic epidermal necrolysis
por: Gupta, Gaurang
Publicado: (2014)

Important Points in Toxic Epidermal Necrolysis Management
por: Al-Shaqsi, Sultan
Publicado: (2019)

Issues about diagnosis and treatment of toxic epidermal necrolysis
por: Besteiro, Beatriz, et al.
Publicado: (2012)

No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients
por: Nardotto, Glauco Henrique Balthazar, et al.
Publicado: (2021)

Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
por: Mukherjee, Aparna, et al.
Publicado: (2015)

A Six-Month Prospective Study to Find Out the Treatment Outcome, Prognosis and Offending Drugs in Toxic Epidermal Necrolysis from an Urban Institution in Kolkata
por: Das, Sudip, et al.
Publicado: (2013)

Comment on: Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy
por: Panigrahi, Pradeep K
Publicado: (2022)

Lethal Toxic Epidermal Necrolysis probably induced by Sinopharm COVID-19 vaccine
por: Seck, B., et al.
Publicado: (2022)

Carbamzepine-induced toxic epidermal necrolysis
por: Chowta, Nithyananda K., et al.
Publicado: (2011)

Response to comment on: Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis, and management of ethambutol-induced optic neuropathy
por: Saxena, Rohit, et al.
Publicado: (2022)

Toxic epidermal necrolysis after yellow fever vaccination
por: Flora, Thaís Bologna, et al.
Publicado: (2018)

Methazolamide-induced toxic epidermal necrolysis in a Chinese woman with HLA-B5901
por: Xu, Yonghao, et al.
Publicado: (2015)

Pruritus as an early sign of abnormal scarring in the re‐epithelialising phase of Toxic Epidermal Necrolysis
por: Frederiks, Aaron J., et al.
Publicado: (2023)

Toxic Epidermal Necrolysis
por: Khalifian, Saami, et al.
Publicado: (2014)

Toxic epidermal necrolysis
por: Hoetzenecker, Wolfram, et al.
Publicado: (2016)

Immune Thrombocytopenic Purpura Associated with Pulmonary Tuberculosis
por: Bairagya, Tapan Das, et al.
Publicado: (2012)

Bronchiolitis obliterans following toxic epidermal necrolysis: a case report
por: Khanal, Ujjwal Prakash, et al.
Publicado: (2021)

A Case of Delusional Disorder With Abuse of Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol, the First-Line Anti-tuberculosis Therapy Drugs in India
por: Sathiyamoorthi, Sathiyanarayanan, et al.
Publicado: (2023)

Serum pyrazinamide concentrations in patients with pulmonary tuberculosis
por: Lucena, Stefania de Medeiros Araujo, et al.
Publicado: (2019)

Nevirapine-induced toxic epidermal necrolysis and psychosis in a human immunodeficiency virus–positive patient
por: Budamakuntla, Leelavathy, et al.
Publicado: (2016)

A Rare Case of Alternative Medicine Induced Toxic Epidermal Necrolysis without Mucosal Involvement
por: Dabas, Rajeshwari, et al.
Publicado: (2019)

Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!
por: Kumar, Rajesh, et al.
Publicado: (2018)

Bronchiolitis obliterans due to toxic epidermal necrolysis - a serious condition with a good therapeutic response
por: Façanha, Ana Lucíola Borges Pinheiro, et al.
Publicado: (2021)

Review of Toxic Epidermal Necrolysis
por: Harris, Victoria, et al.
Publicado: (2016)

Toxic Epidermal Necrolysis and Sepsis
por: Alves, Daniela Dias, et al.
Publicado: (2016)

Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
por: Denti, Paolo, et al.
Publicado: (2015)

Letter in Reply: Important Points in Toxic Epidermal Necrolysis Management
por: Al-Kathiri, Lutfi
Publicado: (2019)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis()
por: Gul, Busra Demirbag, et al.
Publicado: (2022)

Toxic Epidermal Necrolysis in a Patient with HLA-B*5901 Haplotype Caused by Topical and Oral Carbonic Anhydrase Inhibitors
por: Cheon, Minseok, et al.
Publicado: (2014)

Toxic epidermal necrolysis co-existing with severe onset of ulcerative colitis—different condition or extraintestinal feature?—case report
por: Aporowicz, Michał, et al.
Publicado: (2015)

Toxic epidermal necrolysis in an 8-year-old girl successfully treated with cyclosporin A, intravenous immunoglobulin and plasma exchange
por: Zielińska, Marzena, et al.
Publicado: (2018)

Macrophage Activation Syndrome Complicated by Toxic Epidermal Necrolysis Following SARS-CoV-2 mRNA Vaccination
por: Franzblau, Lauren E., et al.
Publicado: (2022)

Lamotrigine induced toxic epidermal necrolysis: A case report
por: KC, Kiran Kumar, et al.
Publicado: (2020)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Rapidly Developing Toxic Epidermal Necrolysis
por: Poulsen, Viktoria Oline Barrios, et al.
Publicado: (2013)

Toxic epidermal necrolysis in hemodialysis patient
por: Mateti, Uday Venkat, et al.
Publicado: (2015)

Early Manifestations of Toxic Epidermal Necrolysis
por: Chapman, James, et al.
Publicado: (2017)

Fulvestrant-induced toxic epidermal necrolysis
por: Morales-Conde, Macarena, et al.
Publicado: (2019)

Immune-Mediated Toxic Epidermal Necrolysis
por: Keerty, Dinesh, et al.
Publicado: (2020)

Allopurinol-Induced Toxic Epidermal Necrolysis
por: Buenrostro-Rubio, Ignacio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3db63d8kg3u4lrg3e6k9fd25e6